Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Critical Review: Treace Medical Concepts (NASDAQ:TMCI) vs. Precision Optics (NASDAQ:POCI)

Дата публикации: 06-07-2026 09:00:05

Precision Optics (NASDAQ:POCI – Get Free Report) and Treace Medical Concepts (NASDAQ:TMCI – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk. Institutional and Insider Ownership 13.7% of […]

Основное содержимое страницы с новостью.

Posted by Tristan Rich on Jul 6th, 2026

Precision Optics (NASDAQ:POCIGet Free Report) and Treace Medical Concepts (NASDAQ:TMCIGet Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

Institutional and Insider Ownership

13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are owned by institutional investors. 14.4% of Precision Optics shares are owned by insiders. Comparatively, 23.4% of Treace Medical Concepts shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Precision Optics and Treace Medical Concepts”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Precision Optics $19.09 million 2.90 -$5.78 million ($0.63) -8.03
Treace Medical Concepts $212.69 million 1.28 -$59.00 million ($0.97) -4.34

Precision Optics has higher earnings, but lower revenue than Treace Medical Concepts. Precision Optics is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Precision Optics has a beta of 0.32, indicating that its stock price is 68% less volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500.

Profitability

This table compares Precision Optics and Treace Medical Concepts’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Precision Optics -17.03% -37.47% -19.96%
Treace Medical Concepts -29.44% -67.04% -30.28%

Analyst Ratings

This is a breakdown of current recommendations for Precision Optics and Treace Medical Concepts, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics 1 0 0 0 1.00
Treace Medical Concepts 2 4 1 0 1.86

Treace Medical Concepts has a consensus price target of $4.77, suggesting a potential upside of 13.30%. Given Treace Medical Concepts’ stronger consensus rating and higher possible upside, analysts plainly believe Treace Medical Concepts is more favorable than Precision Optics.

Summary

Treace Medical Concepts beats Precision Optics on 8 of the 14 factors compared between the two stocks.

About Precision Optics

(Get Free Report)

Precision Optics logoPrecision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

About Treace Medical Concepts

(Get Free Report)

Treace Medical Concepts logoTreace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Receive News & Ratings for Precision Optics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Optics and related companies with MarketBeat.com's FREE daily email newsletter.

You might be interested in:


Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Head to Head Comparison: The Coretec Group (OTCMKTS:CRTG) versus One Stop Systems (NASDAQ:OSS)0506-07-2026
2Analyzing CVRx (NASDAQ:CVRX) and IQVIA (NYSE:IQV)0505-07-2026
3Reviewing Melco International Development (OTCMKTS:MDEVF) and Codere Online Luxembourg (NASDAQ:CDRO)0506-07-2026
4Reviewing Medline (MDLN) and Its Peers0505-07-2026
5Head-To-Head Contrast: China Resources Power (OTCMKTS:CRPJY) vs. United Utilities Group (OTCMKTS:UUGRY)0506-07-2026
6Critical Contrast: Suruga Bank (OTCMKTS:SUGBY) & Flushing Financial (NASDAQ:FFIC)0507-07-2026
7Trevi Therapeutics (NASDAQ:TRVI) Trading Up 5.6% – What’s Next?0507-07-2026
8Intuit (NASDAQ:INTU) & Cadence Design Systems (NASDAQ:CDNS) Financial Contrast0507-07-2026
9Nisun International Enterprise Development Group (NASDAQ:AIOS) & Elmet Group (NASDAQ:ELMT) Head-To-Head Comparison0507-07-2026
10Reviewing Burford Capital (NYSE:BUR) and Perella Weinberg Partners (NASDAQ:PWP)0507-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: www.themarketsdaily.com.